Introduction: Over 2 million adults in the United States have hepatitis C virus (HCV) infection,
and it contributes to approximately 14,000 deaths a year. Eight to 12 weeks of highly …

Liver transplantation is an effective and widely used therapy for several patients with acute
and chronic liver diseases. The discrepancy between the number of patients on the waiting …

Hepatitis C virus infection (HCV) affects approximately 170–200 million individuals globally.
HCV is one of the primary causes of hepatocellular carcinoma (HCC) and cirrhosis and has …

With no approved pharmacological treatment, nonalcoholic fatty liver disease (NAFLD) is
now the most common cause of chronic liver disease in Western countries and its worldwide …

Hepatocellular carcinoma (HCC) is the leading cause of death in patients with cirrhosis.
Patients outside clinical trials seldom benefit from evidence‐based monitoring. The objective …

Results Cancer drug prices are highest in the United States. Cancer drugs are the least
affordable in India by a large margin. Despite lower prices than in the USA, cancer drugs are …

Background & Aims Successful treatment of chronic hepatitis C with oral direct-acting
antivirals (DAAs) leads to virological cure, however, the subsequent risk of hepatocellular …

Abstract In the United States, it is estimated that more than 1.7 million people will be
diagnosed with cancer, and more than 600,000 will die of the disease in 2018. The financial …

The establishment of metabolic zonation within a hepatic lobule ascribes specific functions
to hepatocytes based on unique, location-dependent gene expression patterns. Recently …

The studies of economic burden of chronic diseases have generally been falling behind
similar studies related to their epidemiology, morbidity, and mortality. 1 However …